Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
2016 Science
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2011
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
2013
Clinical implications of epithelial cell plasticity in cancer progression
2015
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer
2016
Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer
2015
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Silibinin suppresses the maintenance of colorectal cancer stem‐like cells by inhibiting PP2A/AKT/mTOR pathways
2011
Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells
2017
Cancer stem cells
2016
RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC)
2017
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Fibrosis and Adipose Tissue Dysfunction
2013 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic
2021 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
2013
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
2015
Oxidative Stress, Epigenetics, and Cancer Stem Cells in Arsenic Carcinogenesis and Prevention
2016
Target cell movement in tumor and cardiovascular diseases based on the epithelial–mesenchymal transition concept
2011
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
2011
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
EMT: 2016
2016 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
2011
Cancer-related inflammation and treatment effectiveness
2014 Standout
A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
2018
From seeing to believing: labelling strategies for in vivo cell-tracking experiments
2013
Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours
2013
Targeting the JAK/STAT pathway in solid tumors
2020
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
2015
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Drug Resistance in Cancer: An Overview
2014 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity
2015
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
2016 StandoutNobel
Works of Khalid Abubaker being referenced
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
2013
Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
2012
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
2010
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
2013
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
2011
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
2014
Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
2014
Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem-like cells leading to a reduced tumor burden
2014